Humacyte, Inc. (HUMA) Net Margin
- 2026-06-30: Net Margin -9064.53%.
- 2026-03-31: Net Margin -3559.39%.
- 2025-12-31: Net Margin -5311.35%.
- 2025-09-30: Net Margin -2325.37%.
Complete source-backed net margin history.
- Available history
- 2020-09-30 to 2026-06-30
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2026-06-30 | -9064.53% |
| 2026-03-31 | -3559.39% |
| 2025-12-31 | -5311.35% |
| 2025-09-30 | -2325.37% |
| 2025-06-30 | -12510.96% |
| 2025-03-31 | 7570.41% |
| 2021-09-30 | -13096.68% |
| 2020-09-30 | -1943.11% |
Annual Net Margin
| Date | Net Margin |
|---|---|
| 2025-12-31 | -2003.58% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |